J&J Unit's $147M Catheter Antitrust Loss Tripled To $442M

By Cara Salvatore · June 6, 2025, 9:03 PM EDT

Johnson & Johnson health tech unit Biosense Webster's bill in an antitrust trial was upped from $147 million to $442 million after a California federal jury found it stifled competition by...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login